Vanguard Personalized Indexing Management’s ResMed RMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.93M | Buy |
30,730
+4,424
| +17% | +$1.14M | 0.09% | 191 |
|
|
2025
Q1 | $5.89M | Buy |
26,306
+2,301
| +10% | +$515K | 0.09% | 202 |
|
|
2024
Q4 | $5.49M | Buy |
24,005
+648
| +3% | +$148K | 0.08% | 203 |
|
|
2024
Q3 | $5.7M | Buy |
23,357
+2,769
| +13% | +$676K | 0.09% | 188 |
|
|
2024
Q2 | $3.89M | Buy |
20,588
+2,175
| +12% | +$411K | 0.07% | 231 |
|
|
2024
Q1 | $3.65M | Buy |
18,413
+715
| +4% | +$142K | 0.08% | 227 |
|
|
2023
Q4 | $3.04M | Buy |
17,698
+10,074
| +132% | +$1.73M | 0.08% | 236 |
|
|
2023
Q3 | $1.13M | Buy |
7,624
+252
| +3% | +$37.3K | 0.03% | 505 |
|
|
2023
Q2 | $1.61M | Sell |
7,372
-98
| -1% | -$21.4K | 0.05% | 370 |
|
|
2023
Q1 | $1.64M | Buy |
7,470
+233
| +3% | +$51K | 0.06% | 350 |
|
|
2022
Q4 | $1.51M | Sell |
7,237
-3,549
| -33% | -$739K | 0.06% | 354 |
|
|
2022
Q3 | $2.36M | Buy |
10,786
+2,392
| +28% | +$522K | 0.11% | 190 |
|
|
2022
Q2 | $1.76M | Buy |
8,394
+2,456
| +41% | +$515K | 0.08% | 243 |
|
|
2022
Q1 | $1.44M | Buy |
5,938
+2,188
| +58% | +$531K | 0.07% | 280 |
|
|
2021
Q4 | $977K | Buy |
3,750
+657
| +21% | +$171K | 0.06% | 402 |
|
|
2021
Q3 | $815K | Buy |
3,093
+536
| +21% | +$141K | 0.07% | 291 |
|
|
2021
Q2 | $630K | Buy |
2,557
+1,056
| +70% | +$260K | 0.07% | 383 |
|
|
2021
Q1 | $291K | Sell |
1,501
-65
| -4% | -$12.6K | 0.04% | 516 |
|
|
2020
Q4 | $333K | Buy |
1,566
+230
| +17% | +$48.9K | 0.07% | 330 |
|
|
2020
Q3 | $229K | Buy |
+1,336
| New | +$229K | 0.06% | 367 |
|